A research study to see if infrared light applied via the nostril is safe and will help reduce symptoms for people with overactive bladder.

Not Applicable

• Conditions: Overactive Bladder; Renal and Urogenital - Other renal and urogenital disorders

• Registration Number: ACTRN12619001012167
• Lead Sponsor: Melbourne Health

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2019-07-15
• Last Update Posted: 22 July 2019

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 6

Inclusion Criteria

•>=20 years of age
•Attending the outpatient continence service for help to manage urinary urgency ±
urgency incontinence; not necessarily treatment naive
•Able to provide informed consent
•Able and willing to participate in the study tasks

Exclusion Criteria

•Known bladder outlet obstruction, moderate to severe voiding dysfunction or
significant cystocele
•High or untreated blood pressure i.e. systolic >150mmHg or diastolic >100mmHg at
baseline measure
•Cognitive impairment that requires care by another person
•Are unable to communicate in English without the service of an interpreter
•Serious medical conditions which are likely to influence their ability to cooperate
•Participating in any other therapeutic trial
•Are starting a new intervention for OAB at the time of the study

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Change in Overactive Bladder Symptom Score (OABSS).<br>The OABSS is a validated, patient-completed sum score of four symptoms (daytime frequency, night time frequency, urgency, and urgency incontinence) seen in patients with OAB, that has been shown to be sensitive to change after treatment.[Immediately after 4-week NIRL intervention.];Change in daytime urinary frequency.<br>Urinary frequency will be recorded with the assistance of the time stamp function on the wrist-worn Actiwatch Spectrum Pro actigraphy device. Participants will be asked to press the button on the device each time they void on 2 days each week for the duration of the study.[ Immediately after 4-week NIRL intervention.]